| Identification | Back Directory | [Name]
2,6-DIBROMO-3-HYDROXYPYRIDINE | [CAS]
6602-33-1 | [Synonyms]
2,6-dibromopyridin-3-ol 3-Pyridinol, 2,6-dibromo- 2,6-DIBROMO-3-HYDROXYPYRIDINE 2,6-DIBROMO-3-HYDROXYPYRIDINE ISO 9001:2015 REACH | [EINECS(EC#)]
229-548-0 | [Molecular Formula]
C5H3Br2NO | [MDL Number]
MFCD01318479 | [MOL File]
6602-33-1.mol | [Molecular Weight]
252.89 |
| Chemical Properties | Back Directory | [Melting point ]
164.0 to 168.0 °C | [Boiling point ]
369.3±37.0 °C(Predicted) | [density ]
2.228±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [solubility ]
soluble in Methanol | [form ]
powder to crystal | [pka]
3.86±0.10(Predicted) | [color ]
White to Light yellow |
| Hazard Information | Back Directory | [Synthesis]
General procedure for the synthesis of 2,6-dibromo-3-hydroxypyridine from 3-hydroxypyridine: Ice-cold bromine (16.2 mL, 315 mmol) was added dropwise to a stirring 2.5 M sodium hydroxide solution (320 mL, 800 mmol). This mixed solution was then slowly added to a 2.5 M sodium hydroxide solution (110 mL, 275 mmol) containing 3-hydroxypyridine (10.0 g, 105 mmol). The reaction mixture was stirred at 0 °C for 1 hour, followed by continued stirring at room temperature for 4 hours. Upon completion of the reaction, a small amount of precipitate was removed by filtration. The filtrate was cooled and the pH was adjusted to 1 with concentrated hydrochloric acid, at which point a solid precipitated. The solid product was collected by filtration, washed with water, dried, and recrystallized from carbon tetrachloride to give 2,6-dibromo-3-hydroxypyridine (12.1 g, 46% yield) as a beige solid. The product was characterized by 1H NMR (400 MHz, DMSO-d6): δ= 11.14 (br s, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.26 (d, J = 8.0 Hz, 1H); mass spectra (ES-ve) m/z: 250, 252, 254 (M-H)-. | [References]
[1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 15, p. 4298 - 4311 [2] Australian Journal of Chemistry, 1981, vol. 34, # 4, p. 927 - 932 [3] Patent: WO2010/56549, 2010, A1. Location in patent: Page/Page column 97 [4] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 24, p. 5630 - 5634 [5] Patent: WO2013/181931, 2013, A1. Location in patent: Page/Page column 40 |
|
|